{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:53:44Z","timestamp":1781484824042,"version":"3.54.1"},"reference-count":36,"publisher":"XMLink","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["wjmh.org"],"crossmark-restriction":false},"short-container-title":["World J Mens Health"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5534\/wjmh.250313","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:56:54Z","timestamp":1770965814000},"page":"582","update-policy":"https:\/\/doi.org\/10.5534\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions"],"prefix":"10.5534","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4072-6142","authenticated-orcid":false,"given":"Alexandra","family":"Naranjo","sequence":"first","affiliation":[{"name":"Prostate Cancer UK, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-111X","authenticated-orcid":false,"given":"Geoffrey Ian","family":"Hackett","sequence":"additional","affiliation":[{"name":"Aston University Medical School, Birmingham, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4303-3238","authenticated-orcid":false,"given":"Sophie","family":"Smith","sequence":"additional","affiliation":[{"name":"Prostate Cancer UK, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-3279","authenticated-orcid":false,"given":"Harley","family":"Stephens","sequence":"additional","affiliation":[{"name":"Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3039-455X","authenticated-orcid":false,"given":"William","family":"Kinnaird","sequence":"additional","affiliation":[{"name":"Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-7714","authenticated-orcid":false,"given":"Mike","family":"Kirby","sequence":"additional","affiliation":[{"name":"Prostate Cancer UK, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","reference":[{"key":"10.5534\/wjmh.250313_ref1","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1007\/s11030-024-11016-2","volume":"29","author":"Nemr","year":"2025","journal-title":"Mol Divers"},{"key":"10.5534\/wjmh.250313_ref2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1751-7176.2012.00669.x","volume":"14","author":"Chrysant","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.5534\/wjmh.250313_ref3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40618-015-0340-5","volume":"39","author":"Corinaldesi","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.5534\/wjmh.250313_ref4","unstructured":"National Institute for Health and Care Excellence. Erectile dysfunction: how common is it? [Internet]. NICE. c2025. cited 2025 Nov 18. Available from: https:\/\/cks.nice.org.uk\/topics\/erectile-dysfunction\/background-information\/prevalence"},{"key":"10.5534\/wjmh.250313_ref5","doi-asserted-by":"crossref","first-page":"e70099","DOI":"10.1002\/edm2.70099","volume":"8","author":"Hostnik","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.5534\/wjmh.250313_ref6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(18)30780-0","volume":"20","author":"Downing","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.5534\/wjmh.250313_ref7","unstructured":"National Institute for Health and Care Excellence (NICE). Erectile dysfunction: phosphodiesterase-5 (PDE-5) inhibitors [Internet]. NICE. c2025. cited 2025 Nov 18. Available from: https:\/\/cks.nice.org.uk\/topics\/erectile-dysfunction\/prescribing-information\/phosphodiesterase-5-pde-5-inhibitors\/"},{"issue":"2 Pt 1","key":"10.5534\/wjmh.250313_ref8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.ju.0000106970.97082.61","volume":"171","author":"Schwartz","year":"2004","journal-title":"J Urol"},{"key":"10.5534\/wjmh.250313_ref9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.urology.2006.05.011","volume":"68","author":"Ferrini","year":"2006","journal-title":"Urology"},{"key":"10.5534\/wjmh.250313_ref10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1464-410X.2007.07223.x","volume":"101","author":"Kovanecz","year":"2008","journal-title":"BJU Int"},{"key":"10.5534\/wjmh.250313_ref11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ijcp.12338","volume":"68","author":"Kirby","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.5534\/wjmh.250313_ref12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7150\/jca.37235","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"key":"10.5534\/wjmh.250313_ref13","doi-asserted-by":"crossref","first-page":"741748","DOI":"10.3389\/fendo.2021.741748","volume":"12","author":"Xin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.5534\/wjmh.250313_ref14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.eururo.2016.07.007","volume":"70","author":"Gacci","year":"2016","journal-title":"Eur Urol"},{"key":"10.5534\/wjmh.250313_ref15","unstructured":"National Institute for Health and Care Clinical Knowledge Summaries. CVD Risk Assessment and management: what are the risk factors? [Internet]. NICE. c2024. cited 2025 Nov 18. Available from: https:\/\/cks.nice.org.uk\/topics\/cvdrisk-assessment-management\/background-information\/riskfactors-for-cvd\/"},{"key":"10.5534\/wjmh.250313_ref16","first-page":"1267","volume":"19","author":"Leitzmann","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.5534\/wjmh.250313_ref17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13685538.2017.1367922","volume":"21","author":"Amano","year":"2018","journal-title":"Aging Male"},{"key":"10.5534\/wjmh.250313_ref18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.01.013","volume":"61","author":"Oelke","year":"2012","journal-title":"Eur Urol"},{"key":"10.5534\/wjmh.250313_ref19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prnil.2024.09.004","volume":"12","author":"Hayakawa","year":"2024","journal-title":"Prostate Int"},{"key":"10.5534\/wjmh.250313_ref20","unstructured":"National Institute for Health and Care Excellence (NICE). Tadalafil [Internet]. NICE. cited 2025 Nov 18. Available from: https:\/\/bnf.nice.org.uk\/drugs\/Tadalafil\/"},{"key":"10.5534\/wjmh.250313_ref21","unstructured":"European Association of Urology (EAU). Management of non-neurogenic male LUTS [Internet]. EAU. c2025. cited 2025 Nov 18. Available from: https:\/\/uroweb.org\/guidelines\/management-of-non-neurogenic-male-luts\/chapter\/disease-management"},{"key":"10.5534\/wjmh.250313_ref22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/JU.0000000000000714","volume":"203","author":"Leong","year":"2020","journal-title":"J Urol"},{"key":"10.5534\/wjmh.250313_ref23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaccao.2024.09.012","volume":"6","author":"Leong","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.5534\/wjmh.250313_ref24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-019-06851-7","volume":"33","author":"Cai","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.5534\/wjmh.250313_ref25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00345-022-04005-3","volume":"40","author":"Goberdhan","year":"2022","journal-title":"World J Urol"},{"key":"10.5534\/wjmh.250313_ref26","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1038\/s41598-019-42592-1","volume":"9","author":"Lawless","year":"2019","journal-title":"Sci Rep"},{"key":"10.5534\/wjmh.250313_ref27","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.3390\/ijms24086984","volume":"24","author":"Kakkat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.5534\/wjmh.250313_ref28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jsxmed\/qdac005","volume":"20","author":"Kloner","year":"2023","journal-title":"J Sex Med"},{"key":"10.5534\/wjmh.250313_ref29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.amjmed.2024.10.039","volume":"138","author":"Jehle","year":"2025","journal-title":"Am J Med"},{"key":"10.5534\/wjmh.250313_ref30","doi-asserted-by":"crossref","first-page":"103035","DOI":"10.1016\/j.eclinm.2024.103035","volume":"80","author":"Kim","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.5534\/wjmh.250313_ref31","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/heartjnl-2016-310746","volume":"103","author":"Andersson","year":"2017","journal-title":"Heart"},{"key":"10.5534\/wjmh.250313_ref32","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/heartjnl-2015-309223","volume":"102","author":"Anderson","year":"2016","journal-title":"Heart"},{"key":"10.5534\/wjmh.250313_ref33","doi-asserted-by":"crossref","first-page":"110704","DOI":"10.1016\/j.radonc.2024.110704","volume":"204","author":"Dahl","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.5534\/wjmh.250313_ref34","unstructured":"National Health Service, England. The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) (Amendment) Regulations 2025 [Internet]. Legislation.gov.uk. c2025. cited 2025 Nov 18. Available from: https:\/\/www.legislation.gov.uk\/uksi\/2025\/987\/made"},{"key":"10.5534\/wjmh.250313_ref35","unstructured":"Community Pharmacy England. Drug Tariff Watch \u2013 October 2025 [Internet]. Community Pharmacy England. c2025. cited 2025 Nov 18. Available from: https:\/\/cpe.org.uk\/our-news\/drug-tariff-watch-october-2025\/"},{"key":"10.5534\/wjmh.250313_ref36","unstructured":"National Health Service England and Wales. NHS Electronic Drug Tariff [Internet]. NHS Business Services Authority. c2025. cited 2025 Nov 18. Available from: https:\/\/www.drugtariff.nhsbsa.nhs.uk\/#\/00899627-DC\/DC00899622\/Home"}],"container-title":["The World Journal of Men's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wjmh.org\/pdf\/10.5534\/wjmh.250313","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wjmh.org\/DOIx.php?id=10.5534\/wjmh.250313","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wjmh.org\/DOIx.php?id=10.5534\/wjmh.250313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:40:47Z","timestamp":1781484047000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjmh.org\/DOIx.php?id=10.5534\/wjmh.250313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5534\/wjmh.250313","relation":{},"ISSN":["2287-4208","2287-4690"],"issn-type":[{"value":"2287-4208","type":"print"},{"value":"2287-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2025-09-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"Copyright \u00a9 2026 Korean Society for Sexual Medicine and Andrology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}